Department of Biochemistry and Molecular Biology lab discovers a link between bacterial and human immunity
The Nemudryi Lab’s research on bacterial Schlafen proteins was highlighted in a May 21 Science news feature that graced the cover.
All Posts by
The Nemudryi Lab’s research on bacterial Schlafen proteins was highlighted in a May 21 Science news feature that graced the cover.
Dr. Barry Byrne and Dr. Matthew Gentry are advancing next-generation gene therapies for rare genetic diseases. Their collaborative research is helping move innovative treatments from discovery to clinical trials, bringing new hope to patients and families.
New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer’s disease.
Research led by Dr. Artem Nemudryi and Dr. Anya Nemudraia has been highlighted in Science, one of the world’s leading scientific journals. The feature article showcases their work on bacterial immune systems and explores how ancient microbial defense mechanisms have shaped modern human immunity. This research contributes to a…
The 6th Annual BMB Undergraduate Poster Symposium was held on April 9, 2026. We would like to thank all of those who presented posters and attended the event. A special thank you to the Office of Graduate Education and the Department of Biochemistry & Molecular Biology for sponsoring this event!…
Congratulation to Jane Hsi-Bell, our Gold Medal Award Winner 2026 Medical Guild Research Symposium! Presentation Title: The Structural Characterization of Antibody-Capsid Interactions Guide the Engineering of AAV9 Gene Therapy Vectors. And special recognition goes to her mentors, Dr. Rob McKenna and Dr. Mario Mietzsch. Background of Medical Guild Symposium:Each Biomedical Sciences advanced concentration puts forward…
Matthew Gentry, Ph.D., an MBI researcher and chair of UF’s Department of Biochemistry and Molecular Biology, is among 10 recipients of the Oxford-Harrington Rare Disease Centre’s 2025 Rare Disease Scholar Awards. The $100,000 awards aim to advance promising lab studies into clinical practice.
We are proud to celebrate Dr. Anna Rushin Nulk’s achievement in successfully defending her dissertation titled “Metabolic Adaptations in the Exocrine Pancreas in Type 1 Diabetes”. This milestone reflects years of dedication, research, and scholarly excellence. Please join us in congratulating Dr. Nulk on this outstanding accomplishment and wishing her…
We are proud to celebrate Dr. Mitch Gulkis’s achievement in successfully defending his dissertation titled “Molecular Structure Across Scales”. This milestone reflects years of dedication, research, and scholarly excellence. Please join us in congratulating Dr. Gulkis on this outstanding accomplishment and wishing him continued success in his academic and professional…
In a new paper, McKnight Brain Institute researchers show capability of a next-generation method to peer into tiny molecules in the brain made by metabolism, the chemical processes that break down food, drugs or chemicals.